Microdosing GLP-1 lacks clinical trial evidence and regulatory approval, making its safety profile unknown
But theres a fine linewhile mild nausea can be tolerated and even beneficial, we dont want it to become debilitating
CrossRef Use of a Diabetes Self-Assessment Score to Predict Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Gyuri Kim, Yong-ho Lee, Young Min Park, Jungghi Kim, Heesuk Kim, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha, Hyun Chul Lee, Dae Jung Kim Medicine.2015
How GLP-1 Therapy May Help with Smoking Cessation Recent studies have shed light on the potential mechanisms by which GLP-1 therapy could aid in quitting smoking or vaping: Reduced Cravings: GLP-1 receptor agonists may decrease the desire to smoke by modulating the brain's reward system